Skip to main content
47°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about XLRN
Recent news which mentions XLRN
3 Dow Stocks to Take Seriously in 2023
November 29, 2022
Tickers
AAPL
BRK-A
BRK-B
HD
Tags
AAPL
MRK
Market News
From
InvestorPlace
Is Merck Stock a Buy?
November 20, 2021
Tickers
GILD
MRK
REGN
XLRN
Tags
MRK
GILD
REGN
From
Motley Fool
Merck Is a Dividend Play Ready to Get Back in Gear
November 16, 2021
Tickers
ABBV
BNTX
MRK
PFE
Tags
XLRN
ABBV
Dividend Stocks
From
InvestorPlace
Is Merck's Planned Acquisition of Acceleron in Trouble?
November 12, 2021
Tickers
MRK
XLRN
Tags
Market News
XLRN
Recent Press Releases
From
Motley Fool
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
Tickers
ACHV
ACIU
AEMD
AGEN
Tags
CRMD
RVNC
REPH
From
Benzinga
3 Dow Stocks That Are Screaming Buys in November
November 09, 2021
Tickers
DJI
IBM
MRK
PFE
Tags
PFE
Market News
Recent Press Releases
From
Motley Fool
3 Best Biotech Stocks to Buy in November
November 08, 2021
Tickers
ABBV
AZN
BMY
MRK
Tags
ABBV
XLRN
AZN
From
Motley Fool
Is Bristol Myers Squibb's Reported Acquisition of Aurinia a Smart Move?
November 06, 2021
Tickers
AUPH
BMY
MRK
XLRN
Tags
MRK
AUPH
BMY
From
Motley Fool
Merck Pushes Acceleron Buyout By Refiling For Antitrust Review
November 01, 2021
Tickers
MRK
XLRN
Tags
Biotech
Market News
Legal
From
Benzinga
2 Top Dividend Stocks That Can Safeguard Your Portfolio Against a Market Crash
October 27, 2021
Tickers
MRK
PFE
TRIL
XLRN
Tags
TRIL
Market News
XLRN
From
Motley Fool
2 Biotech Stocks That Could Go Parabolic This Week
October 24, 2021
Tickers
AUPH
BMY
DWAC
OCGN
Tags
Market News
DWAC
BMY
From
Motley Fool
Bristol Myers Pledges To Offload Acceleron Shares: Bloomberg
October 21, 2021
Tickers
BMY
MRK
XLRN
Tags
Benzinga
Briefs
XLRN
From
Benzinga
2 Best Biotech Stocks to Buy Right Now
October 18, 2021
Tickers
ABBV
AMGN
AZN
BMY
Tags
BMY
MRK
REGN
From
Motley Fool
2 Top Healthcare Stocks That Could Be Bought Out in 2022
October 16, 2021
Tickers
ALLO
ALPMF
BIIB
BLUE
Tags
MRNA
XLRN
ALPMF
From
Motley Fool
Better COVID-19 Stock: Merck or Pfizer?
October 16, 2021
Tickers
BNTX
MRK
PFE
TRIL
Tags
TRIL
PFE
Market News
From
Motley Fool
3 Top Warren Buffett Stocks to Buy in October
October 10, 2021
Tickers
AAPL
BMY
BRK-A
BRK-B
Tags
XLRN
BRK/A
Market News
From
Motley Fool
3 Reasons to Buy Merck Stock Right Now
October 09, 2021
Tickers
MRK
XLRN
Tags
XLRN
Market News
MRK
From
Motley Fool
Is an Acquisition of Acceleron a Smart Move for Merck?
October 08, 2021
Tickers
BMY
MRK
XLRN
Tags
Market News
XLRN
MRK
From
Motley Fool
Expert Ratings For Acceleron Pharma
October 07, 2021
Tickers
XLRN
Tags
Benzinga
Analyst Ratings
BZI/AAR
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2021
October 07, 2021
Tickers
ALLY
ARGX
ATO
BAC
Tags
Intraday Update
VYGR
Initiation
From
Benzinga
Where Acceleron Pharma Stands With Analysts
October 04, 2021
Tickers
XLRN
Tags
BZI/AAR
Analyst Ratings
Benzinga
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 4, 2021
October 04, 2021
Tickers
AKAM
AMPY
AON
CLMT
Tags
BZI/Ratings
AMPY
XLRN
From
Benzinga
The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs And More
October 03, 2021
Tickers
ADVM
ASND
BCYC
CCXI
Tags
RGNX
BCYC
CING
From
Benzinga
Activist Investor Thinks Merck Undervalues Acceleron Buy
October 01, 2021
Tickers
MRK
XLRN
Tags
M&A
Health Care
Movers
From
Benzinga
Expert Ratings For Acceleron Pharma
October 01, 2021
Tickers
XLRN
Tags
Market News
XLRN
BZI/AAR
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 1, 2021
October 01, 2021
Tickers
AADI
ALC
ALIZY
ALZN
Tags
EGLX
GIS
AMZN
From
Benzinga
10 Biggest Price Target Changes For Friday
October 01, 2021
Tickers
BABA
BBBY
DASH
GIS
Tags
Industrials
Price Target
Market News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 30, 2021
September 30, 2021
Tickers
AANNF
ABCB
ABG
ACCD
Tags
PGNY
TPTX
CCCC
From
Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
Tickers
ABBV
ADMA
AGTC
AIM
Tags
SBTX
GRAY
Earnings
From
Benzinga
Merck Seals Acceleron Pharma Deal For $180/Share: Highlights
September 30, 2021
Tickers
BMY
MRK
XLRN
Tags
Health Care
M&A
XLRN
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.